Testing Vespireit for chronic dizziness from autonomic dysfunction
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests a new medication called Vespireit (prolonged-release buspirone) for people with chronic dizziness caused by a problem with the autonomic nervous system. The study aims to see if the drug helps reduce dizziness and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with chronic dizziness or imbalance (functional vertigo) and your symptoms are linked to a problem with your autonomic nervous system (the part that controls automatic body functions like heart rate and blood pressure).
- You are not pregnant, breastfeeding, or planning pregnancy, and you agree to use an effective non-hormonal birth control method (if applicable) during the study and for 3 weeks after.
- You do not have serious heart problems, uncontrolled high blood pressure, epilepsy, Parkinson's disease, certain mental health conditions, or other major medical conditions listed in the eligibility criteria.
- You have not taken certain medications for dizziness or depression in the last 3 weeks, and you are willing to avoid them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will track how current treatments work for adults with vestibular migraine, a condition where migraine causes dizziness and balance problems. It may help doctors learn which options help most in everyday life.
This study tests a new, non-invasive treatment that uses a small electrical device to stimulate the nerves behind the ear. It may help reduce dizziness and migraine symptoms in people who have vestibular migraine, a type of migraine linked to balance problems.
This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This study is testing a device that may help reduce motion sickness and feelings of disorientation. Healthy people who do not usually get motion sickness are needed to participate.
This trial tests a new way to treat a common inner ear condition called BPPV that hasn't improved with standard head maneuvers. It aims to help people whose dizziness keeps coming back.
Hear when a new Vertigo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.